Jay T. Backstrom serves as Executive at ACCELERON PHARMA INC, where they oversee executive responsibilities. Since joining the company, Jay T. Backstrom has executed 7 insider transactions totaling $182.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 16, 2024 involved selling 11,614 shares valued at $182.8K.
Jay T. Backstrom currently holds 352,671 shares of ACCELERON PHARMA INC (XLRN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jay T. Backstrom has been a net seller of XLRN stock. They have purchased $0 and sold $182.8K worth of shares.
Jay T. Backstrom's most recent insider trade was on Feb 16, 2024, when they sold 11,614 shares at $15.74 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 13, 2023 | SRRK | $0 | Award | 150,000 | $N/A | Discretionary |
| Nov 19, 2021 | XLRN | $0 | Tender | 21,233 | $N/A | Discretionary |
| Jan 29, 2021 | XLRN | $0 | Award | 5,409 | $N/A | Discretionary |
| Jan 4, 2021 | XLRN | $215.7K | Payment | 1,735 | $124.31 | Discretionary |
| Jan 2, 2020 | XLRN | $0 | Award | 17,107 | $N/A | Discretionary |